Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
TRIM29 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
gl O-GlcNAc
ga O-GalNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
TRIM29 It is able to complement the radiosensitivity defect of an ataxia telangiectasia (AT) fibroblast cell line. Interacts with VIM and HINT1. Expressed in placenta, prostate and thymus. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Transcription factor
Cellular Component: cytoplasm
Molecular Function: protein binding; zinc ion binding; p53 binding; transcription factor activity
Biological Process: transcription from RNA polymerase II promoter; negative regulation of transcription from RNA polymerase II promoter
Reference #:  Q14134 (UniProtKB)
Alt. Names/Synonyms: Ataxia telangiectasia group D-associated protein; ataxia-telangiectasia group D-associated protein; ATDC; FLJ36085; TRI29; TRIM29; tripartite motif protein TRIM29; tripartite motif-containing 29; Tripartite motif-containing protein 29
Gene Symbols: TRIM29
Molecular weight: 65,835 Da
Basal Isoelectric point: 6.73  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

TRIM29

Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  Phospho3D  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 3 S9-p EAADASRsNGSsPEA
0 3 S13-p ASRsNGSsPEARDAR
0 6 S21-p PEARDARsPsGPSGs
0 3 S23-p ARDARsPsGPSGsLE
0 1 S26 ARsPsGPSGsLENGT
0 1 S28-p sPsGPSGsLENGTKA
0 1 S58-p AEGKSLGsALKPGEG
0 1 S85 PIIQFVESGDDKNsN
0 2 S91-p ESGDDKNsNyFsMDS
0 38 Y93-p GDDKNsNyFsMDSME
0 5 S95-p DKNsNyFsMDSMEGk
1 0 K102-a sMDSMEGkRsPyAGL
0 7 S104-p DSMEGkRsPyAGLQL
0 27 Y106-p MEGkRsPyAGLQLGA
1 0 K116-a LQLGAAKkPPVTFAE
0 1 S130-p EKGELRKsIFsESRK
0 1 S133-p ELRKsIFsESRKPTV
0 2 S141-p ESRKPTVsIMEPGET
0 1 S152-p PGETRRNsYPRADTG
0 1 S164-p DTGLFSRsKsGSEEV
0 1 S166-p GLFSRsKsGSEEVLC
1 0 K275-a ETELSLQkEQLQLKI
1 0 K291-a EIEDEAEkWQKEKDR
1 0 K300-a QKEKDRIkSFTTNEK
1 0 K361-a AKVLHEDkQTREQLH
0 1 T467-p GEWSAPDtMKRysMy
0 4 Y471-p APDtMKRysMyLtPk
0 1 S472-p PDtMKRysMyLtPkG
0 45 Y474-p tMKRysMyLtPkGGV
0 5 T476-p KRysMyLtPkGGVRT
1 0 K478-a ysMyLtPkGGVRTSY
0 10 S489-p RTSYQPSsPGRFTkE
1 0 K495-a SsPGRFTkETTQKNF
0 8 Y506-p QKNFNNLyGtKGNYT
0 4 T508-p NFNNLyGtKGNYTSR
0 2 S540-p VQGSSSFsLKGyPSL
0 10 Y544-p SSFsLKGyPSLMRsQ
1 0 S550-p GyPSLMRsQSPkAQP
1 0 K554-a LMRsQSPkAQPQTWK
  mouse

 
S9-p EGADACRsNGAsPEA
S13-p ACRsNGAsPEARDTR
S21-p PEARDTRsPPGPsGS
P23 ARDTRsPPGPsGSLE
S26-p TRsPPGPsGSLENGT
S28 sPPGPsGSLENGTKA
S58 TEGKTLGSALKSGEG
S85-p PIIQFVEsVDDKGSS
S91 EsVDDKGSSYFSMDS
Y93 VDDKGSSYFSMDSAE
S95 DKGSSYFSMDSAEGR
R102 SMDSAEGRRsPYAGL
S104-p DSAEGRRsPYAGLQL
Y106 AEGRRsPYAGLQLGA
K116 LQLGASKKPPVTFAE
S130 EKGELRKSIFSEPRK
S133 ELRKSIFSEPRKPTV
T141 EPRKPTVTIVEPGEV
S152-p PGEVRRNsYPRADSS
A164 DSSLLARAKSGSEEV
S166 SLLARAKSGSEEVLC
K275 ETELSLQKEQLQLKI
K291 EIEDDVEKWQKEKDR
K300 QKEKDRIKSFTTNEK
K361 AKVLHEDKQTREQLH
T467 NEWSTPDTMKRYSMY
Y471 TPDTMKRYSMYLTPK
S472 PDTMKRYSMYLTPKG
Y474 TMKRYSMYLTPKGGG
T476 KRYSMYLTPKGGGRT
K478 YSMYLTPKGGGRTSY
S489-p RTSYQPSsPSRLSKE
K495 SsPSRLSKETNQKNF
Y506 QKNFNNLYGTKGNYT
T508 NFNNLYGTKGNYTSR
S539 VQGNSSFSLKGFPSL
F543 SSFSLKGFPSLLRSQ
S549 GFPSLLRSQVPKAQP
K553 LLRSQVPKAQPQTWK
  rat

 
S9 EGADASRSNGASPEA
S13 ASRSNGASPEARDAR
S21 PEARDARSPPGPNGS
P23 ARDARSPPGPNGSLE
N26 ARSPPGPNGSLENGT
S28 SPPGPNGSLENGTKA
S58 TEGKTLGSALKSGEG
S85 PIIQFVESVDDKGSS
S91 ESVDDKGSSYFSMDS
Y93 VDDKGSSYFSMDSAE
S95 DKGSSYFSMDSAEGR
R102 SMDSAEGRRSPYAGL
S104 DSAEGRRSPYAGLQL
Y106 AEGRRSPYAGLQLGA
K116 LQLGASKKPPVTFAE
S130 EKGELRKSIFSEPRK
S133 ELRKSIFSEPRKPTV
T141 EPRKPTVTIVEPGEA
S152 PGEARRNSYPRADSS
S164 DSSLLLRSKSGSEEV
S166 SLLLRSKSGSEEVLC
K275 ETELSLQKEQLQLKI
K291 EIEDEAEKWQKEKDR
K300 QKEKDRIKSFTTNEK
K361 AKVLHEDKQTREQLH
T467 NEWSTPDTMKRYSMY
Y471 TPDTMKRYSMYLTPK
S472 PDTMKRYSMYLTPKG
Y474 TMKRYSMYLTPKGGG
T476 KRYSMYLTPKGGGRT
K478 YSMYLTPKGGGRTSY
S489 RTSYQPSSPNRLSKE
K495 SSPNRLSKETNLKNF
Y506 LKNFNNLYGTKGNYT
T508 NFNNLYGTKGNYTSR
S539 VQGNSSFSLKGYPSL
Y543 SSFSLKGYPSLLRSQ
S549 GYPSLLRSQVPKAQP
K553 LLRSQVPKAQPQTWK
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.